OBJECTIVES: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. METHODS: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. RESULTS: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or alpha-tocopherol (<median). Among subjects who had low plasma levels of beta-cryptoxanthin (<73 microg/L), possession of at least 1 copy of the XRCC1 399Gln allele conferred a greater than 2-fold elevated risk (OR [95% CI]: 2.64 [1.40-5.07]). CONCLUSIONS: Our study offers preliminary but intriguing data suggesting that variability in the capacity of repairing oxidative DNA damage influences susceptibility to prostate cancer and that these effects are modified by antioxidants. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVES: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. METHODS: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. RESULTS: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or alpha-tocopherol (<median). Among subjects who had low plasma levels of beta-cryptoxanthin (<73 microg/L), possession of at least 1 copy of the XRCC1 399Gln allele conferred a greater than 2-fold elevated risk (OR [95% CI]: 2.64 [1.40-5.07]). CONCLUSIONS: Our study offers preliminary but intriguing data suggesting that variability in the capacity of repairing oxidative DNA damage influences susceptibility to prostate cancer and that these effects are modified by antioxidants. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: E J Duell; J K Wiencke; T J Cheng; A Varkonyi; Z F Zuo; T D Ashok; E J Mark; J C Wain; D C Christiani; K T Kelsey Journal: Carcinogenesis Date: 2000-05 Impact factor: 4.944
Authors: Carla H van Gils; Roberd M Bostick; Mariana C Stern; Jack A Taylor Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-11 Impact factor: 4.254
Authors: D G Bostwick; E E Alexander; R Singh; A Shan; J Qian; R M Santella; L W Oberley; T Yan; W Zhong; X Jiang; T D Oberley Journal: Cancer Date: 2000-07-01 Impact factor: 6.860
Authors: Jianfeng Xu; Siqun L Zheng; Aubrey Turner; Sarah D Isaacs; Kathy E Wiley; Gregory A Hawkins; Bao-li Chang; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs Journal: Cancer Res Date: 2002-04-15 Impact factor: 12.701
Authors: Ahmed El-Sohemy; Ana Baylin; Edmond Kabagambe; Alberto Ascherio; Donna Spiegelman; Hannia Campos Journal: Am J Clin Nutr Date: 2002-07 Impact factor: 7.045
Authors: Jianjun Zhang; Xuemei Zhang; Ishwori B Dhakal; Myron D Gross; Fred F Kadlubar; Kristin E Anderson Journal: Int J Mol Epidemiol Genet Date: 2011-06-05
Authors: Philip W Kantoff; Lorelei A Mucci; June M Chan; Amy K Darke; Kathryn L Penney; Catherine M Tangen; Phyllis J Goodman; Gwo-Shu Mary Lee; Tong Sun; Sam Peisch; Alex M Tinianow; James M Rae; Eric A Klein; Ian M Thompson Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-06 Impact factor: 4.254
Authors: Erin E Martinez; Amy K Darke; Catherine M Tangen; Phyllis J Goodman; Jay H Fowke; Eric A Klein; Sarki A Abdulkadir Journal: Cancer Prev Res (Phila) Date: 2014-06-03
Authors: Terrence M Vance; Ying Wang; L Joseph Su; Elizabeth T H Fontham; Susan E Steck; Lenore Arab; Jeannette T Bensen; James L Mohler; Ming-Hui Chen; Ock K Chun Journal: Nutr Cancer Date: 2016-02-04 Impact factor: 2.900